FDAnews Announces — Healthcare Innovation and FDA Regulation: Former FDA Commissioner Explains Growing Opportunities for Biomedical Products Webinar, Mar. 19, 2020

Share Article

Take advantage of growing biomedical product opportunities: former FDA Commissioner talks intersection of healthcare innovation, regulation.

WCG FDANews

WCG FDANews

Healthcare Innovation and FDA Regulation
Former FDA Commissioner Explains Growing Opportunities for Biomedical Products
An FDAnews Webinar
Thursday, March 19, 2020 • 11:00 a.m.-12:00 p.m. EDT
https://www.fdanews.com/healthcareinnovation

With an unprecedented number of new, potentially transformative health technologies coming to market in the U.S., there are growing calls to better align the evidence generation that supports regulatory submission and the payment effort that informs patient use and access. Understand the intersection of healthcare innovation and FDA regulation and one will have what one needs to come out on top of this revolution.

Who better than to bring attendees up to speed on the latest developments and trends in this arena than a former FDA Commissioner? Mark McClellan, MD, PhD is currently the Robert J. Margolis Professor of Business, Medicine and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. Dr. McClellan will share:

  • An overview of emerging trends in medical product development, including efforts to further improve development and regulatory review
  • The overall landscape of value-based payment and delivery reforms, and what one must know about their growing linkages to medical product development
  • Increasing concerns associated with the price for transformative medical technologies like gene and cell therapies, and how these anticipated prices are driving stakeholders to explore new types of contract mechanisms and alternative payment models
  • Insight into new policy development areas emerging around challenges with payer coding, coverage and payment processes for innovative medical technologies
  • The growing need for a real-world data and evidence-development infrastructure and its anticipated role in improving your development of medical products as well as regulation and care delivery

If one wants to increasingly provide the right treatments and interventions to the right patients at the right time in this changing landscape of transformative health technologies, you must listen to Dr. McClellan explain the intersection of healthcare innovation and FDA regulation.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:
Healthcare Innovation and FDA Regulation
Former FDA Commissioner Explains Growing Opportunities for Biomedical Products
An FDAnews Webinar
Thursday, March 19, 2020 • 11:00 a.m.-12:00 p.m. EDT
https://www.fdanews.com/healthcareinnovation

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/healthcareinnovation
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDAnews
703.538.7600
Email >
Visit website